TMS-007
- Generic Name
- TMS-007
A Study to Evaluate the Efficacy and Safety of BIIB131 for Participants With Ischemic Stroke Between 4.5 and 24 Hours After Last Known Well
- First Posted Date
- 2023-03-10
- Last Posted Date
- 2024-02-12
- Lead Sponsor
- Biogen
- Registration Number
- NCT05764122
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath